Biotech investors thought they dodged a bullet on Election Day, but drug prices may soon be back in the spotlight.

Time just named President-elect Donald Trump its 2016 Person of the Year. In an interview with Time, Trump was asked about prescription drug prices.

“I’m going to bring down drug prices,” Trump said. “I don’t like what’s happened with drug prices.”

He provided no details about how he intends to accomplish the goal.

Trump’s opponent, Hillary Clinton, made drug prices a centerpiece of her campaign.

Back on September 21, 2015, Clinton responded to a New York Times article on drug prices that mentioned Valeant Pharmaceuticals Intl Inc VRX 0.13% by tweeting, “Price gouging like this in the specialty drug market is outrageous.”

In addition to calling out Valeant for its pricing practices, Clinton also blasted Mylan NV MYL 1.25% for its EpiPen prices.

From the time Clinton sent that tweet on September 21, 2015, up to Election Day, the iShares NASDAQ Biotechnology Index (ETF) IBB 0.43% plummeted…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!